Nihal Sinha
Partner·F-Prime
London, England, UK
Nihal Sinha is a London-based Partner at F-Prime focused primarily on biotech and life sciences in Europe and the U.S. At F-Prime, he was a member of the founding team of Orchard Therapeutics and an investor in Ensoma, Curie Bio, Charm Therapeutics, Aviado Bio, and T-Therapeutics. Before joining F-Prime in 2013, he worked as a strategy consultant at BCG and as an academic physician at Oxford University and UCL Hospitals.
See the rest of Nihal Sinha's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.